Cargando…
Targeting retinoblastoma protein phosphorylation in combination with EGFR inhibition in pancreatic cancer cells
Pancreatic ductal adenocarcinoma (PDAC) remains a particularly lethal disease that is resistant to targeted therapies. Tyrosine kinase inhibitors (TKIs), including erlotinib and gefitinib, which block the action of the human epidermal growth factor receptor type 1 receptor, provide small increases i...
Autores principales: | Thomas, Nimmi A., Abraham, Rita G., Dedi, Brixhilda, Krucher, Nancy A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317693/ https://www.ncbi.nlm.nih.gov/pubmed/30535494 http://dx.doi.org/10.3892/ijo.2018.4658 |
Ejemplares similares
-
Dephosphorylation of the Retinoblastoma protein (Rb) inhibits cancer cell EMT via Zeb
por: Egger, Jacklynn V., et al.
Publicado: (2016) -
Phosphorylation of the Retinoblastoma protein (Rb) on serine-807 is required for association with Bax
por: Antonucci, Lisa A, et al.
Publicado: (2014) -
Newt Myotubes Reenter the Cell Cycle by Phosphorylation of the Retinoblastoma Protein
por: Tanaka, Elly M., et al.
Publicado: (1997) -
Targeting HMGA protein inhibits retinoblastoma cell proliferation
por: Balachandran, Akilandeswari, et al.
Publicado: (2018) -
Immunodetection of retinoblastoma-related protein and its phosphorylated form in interphase and mitotic alfalfa cells
por: Ábrahám, Edit, et al.
Publicado: (2011)